Abstract:Introduction: Epidemiological modeling is widely used to offer insights into the COVID-19 pandemic situation in Asia. We reviewed published computational (mathematical/simulation) models conducted in Asia that assessed impacts of pharmacological and non-pharmacological interventions against COVID-19 and their implications for vaccination strategy. Methods: A search of the PubMed database for peer-reviewed, published, and accessible articles in English was performed up to November 2022 to capture studies in Asian populations based on computational modeling of outcomes in the COVID-19 pandemic. Extracted data included model type (mechanistic compartmental/agent-based, statistical, both), intervention type (pharmacological, non-pharmacological), and procedures for parameterizing age. Findings are summarized with descriptive statistics and discussed in terms of the evolving COVID-19 situation. Results: The literature search identified 378 results, of which 59 met criteria for data extraction. China, Japan, and South Korea accounted for approximately half of studies, with fewer from South and South-East Asia. Mechanistic models were most common, either compartmental (61.0%), agent-based (1.7%), or combination (18.6%) models. Statistical modeling was applied less frequently (11.9%). Pharmacological interventions were examined in 59.3% of studies, and most considered vaccination, except one study of an antiviral treatment. Non-pharmacological interventions were also considered in 84.7% of studies. Infection, hospitalization, and mortality were outcomes in 91.5%, 30.5%, and 30.5% of studies, respectively. Approximately a third of studies accounted for age, including 10 that also examined mortality. Four of these studies emphasized benefits in terms of mortality from prioritizing older adults for vaccination under conditions of a limited supply; however, one study noted potential benefits to infection rates from early vaccination of younger adults. Few studies (5.1%) considered the impact of vaccination among children. Conclusion: Early in the COVID-19 pandemic, non-pharmacological interventions helped to mitigate the health burden of COVID-19; however, modeling indicates that high population coverage of effective vaccines will complement and reduce reliance on such interventions. Thus, increasing and maintaining immunity levels in populations through regular booster shots, particularly among at-risk and vulnerable groups, including older adults, might help to protect public health. Future modeling efforts should consider new vaccines and alternative therapies alongside an evolving virus in populations with varied vaccination histories.

Modeling the potential public health impact of different vaccination strategies with an adapted vaccine in South Africa

Assessing Vaccination Prioritization Strategies for COVID-19 in South Africa Based on Age-Specific Compartment Model

Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis

Modelling the impact of vaccination on COVID-19 in African countries

Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns

COVID-19 transmission dynamics and the impact of vaccination: modelling, analysis and simulations

Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India

Modeling Framework to Evaluate Vaccine Strategies against the COVID-19 Pandemic

Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants.

The impact of human behavioral adaptation stratified by immune status on COVID-19 spread with application to South Korea

Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach

Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in Asia

Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub

Modeling the potential public health and economic impact of different COVID-19 booster dose vaccination strategies with an adapted vaccine in the United Kingdom

Vaccination compartmental epidemiological models for the delta and omicron SARS-CoV-2 variants

Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study

How to Model the Impact of Vaccines for Policymaking When the Characteristics are Uncertain: A Case Study in Thailand Prior to the Vaccine Rollout During the COVID-19 Pandemic

Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review

Modeling the health impact of increasing vaccine coverage and nonpharmaceutical interventions against coronavirus disease 2019 in Ghana

Evaluating vaccination timing, hesitancy and effectiveness to prevent future outbreaks: insights from COVID-19 modelling and transmission dynamics

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines